Found 243 bookmarks
Newest
21. pH-sensitive chitosan-based nanoparticles for protein drug delivery: oral approaches: Original research article: a novel pH-sensitive hydrogel composed of carboxymethyl chitosan and alginate cross-linked by genipin for protein drug delivery, 2004 - PubMed
21. pH-sensitive chitosan-based nanoparticles for protein drug delivery: oral approaches: Original research article: a novel pH-sensitive hydrogel composed of carboxymethyl chitosan and alginate cross-linked by genipin for protein drug delivery, 2004 - PubMed
21. pH-sensitive chitosan-based nanoparticles for protein drug delivery: oral approaches: Original research article: a novel pH-sensitive hydrogel composed of carboxymethyl chitosan and alginate cross-linked by genipin for protein drug delivery, 2004
·pubmed.ncbi.nlm.nih.gov·
21. pH-sensitive chitosan-based nanoparticles for protein drug delivery: oral approaches: Original research article: a novel pH-sensitive hydrogel composed of carboxymethyl chitosan and alginate cross-linked by genipin for protein drug delivery, 2004 - PubMed
20. Multi-targeting system with fusion between thermoresponsive carriers and mild hyperthermia: Original research article: Thermo-responsive drug delivery from polymeric micelles constructed using block copolymers of poly(N-isopropylacrylamide) and poly(butylmethacrylate) (1999) - PubMed
20. Multi-targeting system with fusion between thermoresponsive carriers and mild hyperthermia: Original research article: Thermo-responsive drug delivery from polymeric micelles constructed using block copolymers of poly(N-isopropylacrylamide) and poly(butylmethacrylate) (1999) - PubMed
20. Multi-targeting system with fusion between thermoresponsive carriers and mild hyperthermia: Original research article: Thermo-responsive drug delivery from polymeric micelles constructed using block copolymers of poly(N-isopropylacrylamide) and poly(butylmethacrylate) (1999)
·pubmed.ncbi.nlm.nih.gov·
20. Multi-targeting system with fusion between thermoresponsive carriers and mild hyperthermia: Original research article: Thermo-responsive drug delivery from polymeric micelles constructed using block copolymers of poly(N-isopropylacrylamide) and poly(butylmethacrylate) (1999) - PubMed
19. Targeted nanoparticles for smarter cancer therapy: Original research article: Folate receptor targeted biodegradable polymeric doxorubicin micelles, 2004 - PubMed
18. Biodegradable block copolymers for delivery of proteins and water-insoluble drugs: reflections and commentary a decade later: Original research article: Biodegradable block copolymers for delivery and proteins water-insoluble drugs, 2001 - PubMed
18. Biodegradable block copolymers for delivery of proteins and water-insoluble drugs: reflections and commentary a decade later: Original research article: Biodegradable block copolymers for delivery and proteins water-insoluble drugs, 2001 - PubMed
18. Biodegradable block copolymers for delivery of proteins and water-insoluble drugs: reflections and commentary a decade later: Original research article: Biodegradable block copolymers for delivery and proteins water-insoluble drugs, 2001
·pubmed.ncbi.nlm.nih.gov·
18. Biodegradable block copolymers for delivery of proteins and water-insoluble drugs: reflections and commentary a decade later: Original research article: Biodegradable block copolymers for delivery and proteins water-insoluble drugs, 2001 - PubMed
17. Histidine based pH-responsive polymeric micelle for tumor: Original research article: Polymeric micelle for tumor pH folate-mediated targeting, 2003 - PubMed
15. Vitamin E TPGS based nanoparticles of biodegradable polymers for controlled release of anticancer drugs: Original research article: a novel controlled release formulation for the anticancer drug paclitaxel (Taxol): PLGA nanoparticles containing vitamin E TPGS (2003) - PubMed
15. Vitamin E TPGS based nanoparticles of biodegradable polymers for controlled release of anticancer drugs: Original research article: a novel controlled release formulation for the anticancer drug paclitaxel (Taxol): PLGA nanoparticles containing vitamin E TPGS (2003) - PubMed
15. Vitamin E TPGS based nanoparticles of biodegradable polymers for controlled release of anticancer drugs: Original research article: a novel controlled release formulation for the anticancer drug paclitaxel (Taxol): PLGA nanoparticles containing vitamin E TPGS (2003)
·pubmed.ncbi.nlm.nih.gov·
15. Vitamin E TPGS based nanoparticles of biodegradable polymers for controlled release of anticancer drugs: Original research article: a novel controlled release formulation for the anticancer drug paclitaxel (Taxol): PLGA nanoparticles containing vitamin E TPGS (2003) - PubMed
13. From tissue engineering to therapeutic cancer vaccines: Original research article: Bioabsorbable polymer scaffolds for tissue engineering capable of sustained growth factor delivery, 2000 - PubMed
13. From tissue engineering to therapeutic cancer vaccines: Original research article: Bioabsorbable polymer scaffolds for tissue engineering capable of sustained growth factor delivery, 2000 - PubMed
13. From tissue engineering to therapeutic cancer vaccines: Original research article: Bioabsorbable polymer scaffolds for tissue engineering capable of sustained growth factor delivery, 2000
·pubmed.ncbi.nlm.nih.gov·
13. From tissue engineering to therapeutic cancer vaccines: Original research article: Bioabsorbable polymer scaffolds for tissue engineering capable of sustained growth factor delivery, 2000 - PubMed
12. Biodegradable polymer nanoparticles as protein delivery systems: Original research articles: Design of biodegradable particles for protein delivery (2002), Chitosan nanoparticles as delivery systems for doxorubicin (2001); design of microencapsulated chitosan microspheres for colonic drug delivery (1998) - PubMed
12. Biodegradable polymer nanoparticles as protein delivery systems: Original research articles: Design of biodegradable particles for protein delivery (2002), Chitosan nanoparticles as delivery systems for doxorubicin (2001); design of microencapsulated chitosan microspheres for colonic drug delivery (1998) - PubMed
12. Biodegradable polymer nanoparticles as protein delivery systems: Original research articles: Design of biodegradable particles for protein delivery (2002), Chitosan nanoparticles as delivery systems for doxorubicin (2001); design of microencapsulated chitosan microspheres for colonic drug delivery (1998)
·pubmed.ncbi.nlm.nih.gov·
12. Biodegradable polymer nanoparticles as protein delivery systems: Original research articles: Design of biodegradable particles for protein delivery (2002), Chitosan nanoparticles as delivery systems for doxorubicin (2001); design of microencapsulated chitosan microspheres for colonic drug delivery (1998) - PubMed
11. Biodegradable electrospun fibers as drug delivery system for local cancer treatment: a rugged path to the bright future: Original research article: Biodegradable electrospun fibers for drug delivery, 2003 - PubMed
11. Biodegradable electrospun fibers as drug delivery system for local cancer treatment: a rugged path to the bright future: Original research article: Biodegradable electrospun fibers for drug delivery, 2003 - PubMed
11. Biodegradable electrospun fibers as drug delivery system for local cancer treatment: a rugged path to the bright future: Original research article: Biodegradable electrospun fibers for drug delivery, 2003
·pubmed.ncbi.nlm.nih.gov·
11. Biodegradable electrospun fibers as drug delivery system for local cancer treatment: a rugged path to the bright future: Original research article: Biodegradable electrospun fibers for drug delivery, 2003 - PubMed
10. Biophysics of cell membrane and nanoparticle interface: Original research article: Residual polyvinyl alcohol associated with poly (D,L-lactide-co-glycolide) nanoparticles affects their physical properties and cellular uptake, 2002 - PubMed
10. Biophysics of cell membrane and nanoparticle interface: Original research article: Residual polyvinyl alcohol associated with poly (D,L-lactide-co-glycolide) nanoparticles affects their physical properties and cellular uptake, 2002 - PubMed
10. Biophysics of cell membrane and nanoparticle interface: Original research article: Residual polyvinyl alcohol associated with poly (D,L-lactide-co-glycolide) nanoparticles affects their physical properties and cellular uptake, 2002
·pubmed.ncbi.nlm.nih.gov·
10. Biophysics of cell membrane and nanoparticle interface: Original research article: Residual polyvinyl alcohol associated with poly (D,L-lactide-co-glycolide) nanoparticles affects their physical properties and cellular uptake, 2002 - PubMed
9. Diagnostic and therapeutic applications of biocompatible gold nanorods: Original research article: PEG-modified gold nanorods with a stealth character for in vivo applications, 2006 - PubMed
9. Diagnostic and therapeutic applications of biocompatible gold nanorods: Original research article: PEG-modified gold nanorods with a stealth character for in vivo applications, 2006 - PubMed
9. Diagnostic and therapeutic applications of biocompatible gold nanorods: Original research article: PEG-modified gold nanorods with a stealth character for in vivo applications, 2006
·pubmed.ncbi.nlm.nih.gov·
9. Diagnostic and therapeutic applications of biocompatible gold nanorods: Original research article: PEG-modified gold nanorods with a stealth character for in vivo applications, 2006 - PubMed
8. Chitosan and chitosan oligomers for nucleic acid delivery: Original research article: Chitosan and depolymerized chitosan oligomers as condensing carriers for in vivo plasmid delivery, 1998 - PubMed
8. Chitosan and chitosan oligomers for nucleic acid delivery: Original research article: Chitosan and depolymerized chitosan oligomers as condensing carriers for in vivo plasmid delivery, 1998 - PubMed
8. Chitosan and chitosan oligomers for nucleic acid delivery: Original research article: Chitosan and depolymerized chitosan oligomers as condensing carriers for in vivo plasmid delivery, 1998
·pubmed.ncbi.nlm.nih.gov·
8. Chitosan and chitosan oligomers for nucleic acid delivery: Original research article: Chitosan and depolymerized chitosan oligomers as condensing carriers for in vivo plasmid delivery, 1998 - PubMed
7. Ethosomes - an innovative carrier for enhanced delivery into and across the skin: Original research article: Ethosomes - novel vesicular carriers for enhanced delivery: characterization skin penetration properties, 2000 - PubMed
6. Reflections on the emergence of new thematic research: development of electrospun nanostructured DNA delivery scaffolds: Original research article: Development of a nanostructured DNA delivery scaffold via electrospinning of PLGA PLA-PEG block copolymers, 2003 - PubMed
6. Reflections on the emergence of new thematic research: development of electrospun nanostructured DNA delivery scaffolds: Original research article: Development of a nanostructured DNA delivery scaffold via electrospinning of PLGA PLA-PEG block copolymers, 2003 - PubMed
6. Reflections on the emergence of new thematic research: development of electrospun nanostructured DNA delivery scaffolds: Original research article: Development of a nanostructured DNA delivery scaffold via electrospinning of PLGA PLA-PEG block copolymers, 2003
·pubmed.ncbi.nlm.nih.gov·
6. Reflections on the emergence of new thematic research: development of electrospun nanostructured DNA delivery scaffolds: Original research article: Development of a nanostructured DNA delivery scaffold via electrospinning of PLGA PLA-PEG block copolymers, 2003 - PubMed
4. Poly(NIPAAm) revisited - it has been 28 years since it was first proposed for use as a biomaterial: Original research article: Applications of thermally reversible polymers hydrogels in therapeutics and diagnostics, 1987; thermally reversible hydrogels: II. Delivery and selective removal of substances from aqueous solutions, 1986; a novel approach for preparation of pH-sensitive hydrogels for enteric drug delivery, 1991 - PubMed
4. Poly(NIPAAm) revisited - it has been 28 years since it was first proposed for use as a biomaterial: Original research article: Applications of thermally reversible polymers hydrogels in therapeutics and diagnostics, 1987; thermally reversible hydrogels: II. Delivery and selective removal of substances from aqueous solutions, 1986; a novel approach for preparation of pH-sensitive hydrogels for enteric drug delivery, 1991 - PubMed
4. Poly(NIPAAm) revisited - it has been 28 years since it was first proposed for use as a biomaterial: Original research article: Applications of thermally reversible polymers hydrogels in therapeutics and diagnostics, 1987; thermally reversible hydrogels: II. Delivery and selective removal of substances from aqueous solutions, 1986; a novel approach for preparation of pH-sensitive hydrogels for enteric drug delivery, 1991
·pubmed.ncbi.nlm.nih.gov·
4. Poly(NIPAAm) revisited - it has been 28 years since it was first proposed for use as a biomaterial: Original research article: Applications of thermally reversible polymers hydrogels in therapeutics and diagnostics, 1987; thermally reversible hydrogels: II. Delivery and selective removal of substances from aqueous solutions, 1986; a novel approach for preparation of pH-sensitive hydrogels for enteric drug delivery, 1991 - PubMed
5. A short commentary on stimuli-responsive hydrogels for drug delivery: Original research article: Thermally on-off switching polymers for drug permeation release, 1990 - PubMed
1. Commentary on an exponential model for the analysis of drug delivery: Original research article: a simple equation for description of solute release: I II. Fickian and non-Fickian release from non-swellable devices in the form of slabs, spheres, cylinders or discs, 1987 - PubMed
1. Commentary on an exponential model for the analysis of drug delivery: Original research article: a simple equation for description of solute release: I II. Fickian and non-Fickian release from non-swellable devices in the form of slabs, spheres, cylinders or discs, 1987 - PubMed
1. Commentary on an exponential model for the analysis of drug delivery: Original research article: a simple equation for description of solute release: I II. Fickian and non-Fickian release from non-swellable devices in the form of slabs, spheres, cylinders or discs, 1987
·pubmed.ncbi.nlm.nih.gov·
1. Commentary on an exponential model for the analysis of drug delivery: Original research article: a simple equation for description of solute release: I II. Fickian and non-Fickian release from non-swellable devices in the form of slabs, spheres, cylinders or discs, 1987 - PubMed
3. Electrospun polymer fibers as a versatile delivery platform for small molecules and macromolecules: Original research article: Release of tetracycline hydrochloride from electrospun poly (ethylene-co-vinylacetate), poly (lactic acid), a blend, 2002 - PubMed
3. Electrospun polymer fibers as a versatile delivery platform for small molecules and macromolecules: Original research article: Release of tetracycline hydrochloride from electrospun poly (ethylene-co-vinylacetate), poly (lactic acid), a blend, 2002 - PubMed
3. Electrospun polymer fibers as a versatile delivery platform for small molecules and macromolecules: Original research article: Release of tetracycline hydrochloride from electrospun poly (ethylene-co-vinylacetate), poly (lactic acid), a blend, 2002
·pubmed.ncbi.nlm.nih.gov·
3. Electrospun polymer fibers as a versatile delivery platform for small molecules and macromolecules: Original research article: Release of tetracycline hydrochloride from electrospun poly (ethylene-co-vinylacetate), poly (lactic acid), a blend, 2002 - PubMed
The ancient vocabulary of medical prescriptions - PubMed
8th Pieter van Keep Memorial Lecture. Estrogen and bone: have we completed a full circle? - PubMed
8th Pieter van Keep Memorial Lecture. Estrogen and bone: have we completed a full circle? - PubMed
Estrogen therapy was considered first-line therapy for the prevention and treatment of postmenopausal osteoporosis in 1984. Evidence from a large, randomized clinical trial in 2002 proved the efficacy of estrogen in the prevention of all types of osteoporosis-related fractures. Ironically, estrogen …
·pubmed.ncbi.nlm.nih.gov·
8th Pieter van Keep Memorial Lecture. Estrogen and bone: have we completed a full circle? - PubMed
Preoperative antibiotic colon preparation: have we had the answer all along? - PubMed
Oral rehydration therapy in cholera - PubMed
Clinical research before informed consent - PubMed
In honour of Professor Kazunori Kataoka, recipient of the Journal of Drug Targeting's Life-time Achievement Award for 2014 - PubMed
Opioid dependence, a life-threatening condition, is preventable - PubMed
Opioid substitution treatment in New Zealand: a 40 year perspective - PubMed
Opioid substitution treatment in New Zealand: a 40 year perspective - PubMed
We provide an overview of the history and philosophy of the treatment for opioid dependence, which has been dominated by methadone substitution treatment for the past 40 years in New Zealand. Although changes in approach have occurred over this time, influenced by various sociopolitical events and c …
·pubmed.ncbi.nlm.nih.gov·
Opioid substitution treatment in New Zealand: a 40 year perspective - PubMed
An integrated approach to individualized optimal dose estimation of medication by means of dosing adjustment measures and Bi-Digital O-Ring Test - PubMed
An integrated approach to individualized optimal dose estimation of medication by means of dosing adjustment measures and Bi-Digital O-Ring Test - PubMed
Posology concerns science and system of dosage. Conventionally the dosage systems of measurement are the apothecaries' and metric systems and the dosage calculation for each individual patient has been suggested according to several available methods, namely Clark's Rule, Fried's Rule, Young's Rule, …
·pubmed.ncbi.nlm.nih.gov·
An integrated approach to individualized optimal dose estimation of medication by means of dosing adjustment measures and Bi-Digital O-Ring Test - PubMed
"Take your pill": the role and fantasy of pills in modern medicine - PubMed
"Take your pill": the role and fantasy of pills in modern medicine - PubMed
The pharmaceutical industry has undergone a vast expansion in the 20th and 21st centuries. This article explores the central role now played by pills in clinical practice, but also in the public imagination. First, this article analyzes four properties that, together, account for many of the promise …
·pubmed.ncbi.nlm.nih.gov·
"Take your pill": the role and fantasy of pills in modern medicine - PubMed
Controlled drug delivery systems: past forward and future back - PubMed
Advocating for opioid substitution therapy in Central Asia: much still to be done - PubMed
Advocating for opioid substitution therapy in Central Asia: much still to be done - PubMed
Opioid substitution therapy (OST) was first introduced in the formerly-Soviet Central Asian Republics as an HIV prevention intervention for people who inject drugs (PWID) in 2002. Presently, pilot programs function in Kazakhstan and Tajikistan, and Kyrgyzstan has scaled-up from the pilot phase to th …
·pubmed.ncbi.nlm.nih.gov·
Advocating for opioid substitution therapy in Central Asia: much still to be done - PubMed